Video Experimental Relacionado
Updated: Jul 15, 2026
12:37
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
vasoconstricción coronaria alfa-adrenérgica y isquemia miocárdica en humanos
G Heusch1, D Baumgart, P Camici
1Abteilung für Pathophysiologie and Abteilung für Kardiologie, Universitätsklinikum Essen, Essen, Germany. gerd.heusch@uni-essen.de
Circulation
|February 15, 2000
Resumen
La constricción coronaria alfa-adrenérgica no está presente en reposo, pero se amplifica en condiciones como la disfunción endotelial y la aterosclerosis. Esta constricción amplificada puede causar isquemia miocárdica y deterioro de la función cardíaca.
Área de la Ciencia:
- Cardiología Cardiología.
- Farmacología Farmacología.
- Fisiología Fisiología Fisiología.
Sus antecedentes:
- La vasomoción coronaria alfa-adrenérgica es crucial para regular el flujo sanguíneo al corazón.
- Estudios previos en animales sugirieron un papel para los receptores alfa-adrenérgicos en las arterias coronarias.
Objetivo del estudio:
- Para investigar la vasomoción coronaria alfa-adrenérgica en humanos.
- Determinar el papel de la activación del alfa-adrenoceptor en la disfunción endotelial coronaria y la aterosclerosis.
Principales métodos:
- La angiografía coronaria cuantitativa es una angiografía coronaria cuantitativa.
- Las mediciones Doppler son mediciones Doppler.
- Tomografía por emisión de positrones (PET)
Principales resultados:
- No hay evidencia de tono constrictor coronario alfa-adrenérgico en reposo en humanos.
- La activación del alfa-adrenoceptor aumentó significativamente la constricción coronaria en presencia de disfunción endotelial y aterosclerosis.
- Los receptores alfa-1 y alfa-2 en las arterias epicárdicas y los microvasculares estuvieron involucrados.
- Se produjo una mayor constricción durante el ejercicio y las intervenciones, lo que condujo a isquemia miocárdica y reducción de la función cardíaca.
- Los hallazgos recientes sugieren una influencia genética en la constricción coronaria alfa-adrenérgica.
Conclusiones:
- La constricción coronaria alfa-adrenérgica no es un factor en reposo, pero se vuelve significativa bajo condiciones patológicas.
- La disfunción endotelial y la aterosclerosis mejoran las respuestas alfa-adrenérgicas, causando potencialmente isquemia.
- Las vías alfa-adrenérgicas, en particular las que involucran a los receptores alfa ((2), son objetivos clave para la comprensión y el manejo de la enfermedad arterial coronaria.
Videos de Conceptos Relacionados
01:27Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...